HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PKCθ-JunB axis via upregulation of VEGFR3 expression mediates hypoxia-induced pathological retinal neovascularization.

Abstract
Pathological retinal neovascularization is the most common cause of vision loss. PKCθ has been shown to play a role in type 2 diabetes, which is linked to retinal neovascularization. Based on these clues, we have studied the role of PKCθ and its downstream target genes JunB and VEGFR3 in retinal neovascularization using global and tissue-specific knockout mouse models along with molecular biological approaches. Here, we show that vascular endothelial growth factor A (VEGFA) induces PKCθ phosphorylation in human retinal microvascular endothelial cells (HRMVECs) and downregulation of its levels attenuates VEGFA-induced HRMVECs migration, sprouting and tube formation. Furthermore, the whole body deletion of PKCθ or EC-specific deletion of its target gene JunB inhibited hypoxia-induced retinal EC proliferation, tip cell formation and neovascularization. VEGFA also induced VEGFR3 expression via JunB downstream to PKCθ in the regulation of HRMVEC migration, sprouting, and tube formation in vitro and OIR-induced retinal EC proliferation, tip cell formation and neovascularization in vivo. In addition, VEGFA-induced VEGFR3 expression requires VEGFR2 activation upstream to PKCθ-JunB axis both in vitro and in vivo. Depletion of VEGFR2 or VEGFR3 levels attenuated VEGFA-induced HRMVEC migration, sprouting and tube formation in vitro and retinal neovascularization in vivo and it appears that these events were dependent on STAT3 activation. Furthermore, the observations using soluble VEGFR3 indicate that VEGFR3 mediates its effects on retinal neovascularization in a ligand dependent and independent manner downstream to VEGFR2. Together, these observations suggest that PKCθ-dependent JunB-mediated VEGFR3 expression targeting STAT3 activation is required for VEGFA/VEGFR2-induced retinal neovascularization.
AuthorsRaj Kumar, Arul M Mani, Nikhlesh K Singh, Gadiparthi N Rao
JournalCell death & disease (Cell Death Dis) Vol. 11 Issue 5 Pg. 325 (05 07 2020) ISSN: 2041-4889 [Electronic] England
PMID32382040 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • JunB protein, human
  • Ligands
  • Transcription Factors
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor Receptor-3
  • Protein Kinase C-theta
Topics
  • Animals
  • Cell Movement (drug effects, genetics)
  • Endothelial Cells (drug effects, metabolism)
  • Humans
  • Hypoxia (complications)
  • Ligands
  • Mice, Inbred C57BL
  • Neovascularization, Physiologic (drug effects, genetics)
  • Promoter Regions, Genetic (genetics)
  • Protein Kinase C-theta (metabolism)
  • Retinal Neovascularization (etiology, genetics, pathology)
  • Signal Transduction (drug effects)
  • Transcription Factors (metabolism)
  • Up-Regulation (drug effects, genetics)
  • Vascular Endothelial Growth Factor A (pharmacology)
  • Vascular Endothelial Growth Factor Receptor-3 (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: